NCT00046033View on ClinicalTrials.gov

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

PHASE2CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

Not specified

Primary Completion Date

March 31, 2003

Conditions
HIV Infections
Interventions
DRUG

Lopinavir/ritonavir

DRUG

Ritonavir

DRUG

Saquinavir

DRUG

Tenofovir disoproxil fumarate

DRUG

Amprenavir

Trial Locations (6)

10016

NYU/Bellevue, New York

44106

Case Western Reserve Univ, Cleveland

33136-1013

Univ of Miami, Miami

96816-2396

Univ of Hawaii, Honolulu

15213-2582

Univ of Pittsburgh, Pittsburgh

77555-0435

Univ of Texas, Galveston, Galveston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH